Apyx Medical Corporation Reports Second Quarter 2020 Financial Results
CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation (NASDAQ:APYX) (the Company), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today reported financial results for its second quarter ended June 30, 2020.
Second Quarter 2020 Financial Summary:
Total revenue of $4.3 million, down 35% year-over-year.
- Advanced Energy reve…